Recently, RBP2 was identified as one chromatin-modifying enzyme that participates in the carcinogenesis and progression of human cancers such as lung cancer [16], gastric cancer [17–20] and breast cancer [21]. This evidence concerns the gene RBP2 and lung carcinoma.